A detailed history of Advisors Asset Management, Inc. transactions in Legend Biotech Corp stock. As of the latest transaction made, Advisors Asset Management, Inc. holds 6,812 shares of LEGN stock, worth $273,706. This represents 0.01% of its overall portfolio holdings.

Number of Shares
6,812
Previous 5,975 14.01%
Holding current value
$273,706
Previous $264,000 25.38%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$43.55 - $59.88 $36,451 - $50,119
837 Added 14.01%
6,812 $331,000
Q2 2024

Aug 14, 2024

BUY
$39.5 - $57.22 $58,499 - $84,742
1,481 Added 32.96%
5,975 $264,000
Q1 2024

May 14, 2024

BUY
$55.06 - $69.99 $109,844 - $139,630
1,995 Added 79.83%
4,494 $252,000
Q4 2023

Feb 14, 2024

BUY
$57.25 - $69.74 $99,042 - $120,650
1,730 Added 224.97%
2,499 $150,000
Q2 2023

Aug 14, 2023

BUY
$46.28 - $75.01 $35,589 - $57,682
769 New
769 $53,000

Others Institutions Holding LEGN

About Legend Biotech Corp


  • Ticker LEGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 167,403,008
  • Market Cap $6.73B
  • Description
  • Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...
More about LEGN
Track This Portfolio

Track Advisors Asset Management, Inc. Portfolio

Follow Advisors Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisors Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisors Asset Management, Inc. with notifications on news.